Article preview reprinted Medtech Insight - October 2008
Find out how at this year's meeting of the Congress of the European Society of Cataract and Refractive Surgeons, market leaders made headlines with news of joint ventures in refractive surgery, new product launches and re-launches, and other glimpses into the future of vision correction technology.
ESCRS: Zooming in on Vision Innovations
Article preview reprinted Medtech Insight - October 2008
Each September, the Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) provides a look into the future of vision correction technology. This year in Berlin, Bausch & Lomb Inc. (B&L) made headlines with the announcement of a new joint venture to address the refractive surgery market, the introduction of an innovative new laser-based procedure for presbyopia correction, and the European re-launch of the Crystalens accommodating intraocular lens (IOL) for presbyopia. Ophthalmology market leader Alcon Laboratories Inc./Nestle SA announced two major international product launches: an important new version of the ReSTOR multifocal presbyopia-correcting IOL (PCIOL), and a promising new phakic IOL for elective correction of moderate to high levels of myopia (nearsightedness).
Purchase this 2930-word article online as a PDF for just $125 and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed.
Companies mentioned in this article:
20 10 Perfect Vision Optische Gerate GMBH
Advanced Medical Optics Inc.
Bausch & Lomb Inc.
eyeonics Inc.
Calhoun Vision Inc.
Carl Zeiss AG
Carl Zeiss Meditech AG
Carl Zeiss Meditec Inc.
Nestle SA Alcon Inc.
Alcon Laboratories Inc.
Staar Surgical Co.
Ziemer Ophthalmic Systems AG
Medtech Insight delivers the quality content you need on medical technologies impacting the spectrum of surgical, orthopedic, cardiovascular, and other markets. Written and edited by seasoned industry participants and experts, the Medtech Insight newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc.) impacting a wide range of surgical and non-surgical clinical practices (cardiothoracic & vascular surgery, general surgery, orthopedics & spine surgery, interventional radiology/cardiology, etc.). Learn more at www.medtechinsight.com.
